Prediction of the 3D Structure and Dynamics of Human DP G-Protein Coupled Receptor Bound to an Agonist and an Antagonist
Abstract
Prostanoids play important physiological roles in the cardiovascular and immune systems and in pain sensation in peripheral systems through their interactions with eight G-protein coupled receptors. These receptors are important drug targets, but development of subtype specific agonists and antagonists has been hampered by the lack of 3D structures for these receptors. We report here the 3D structure for the human DP G-protein coupled receptor (GPCR) predicted by the MembStruk computational method. To validate this structure, we use the HierDock computational method to predict the binding mode for the endogenous agonist (PGD2) to DP. Based on our structure, we predicted the binding of different antagonists and optimized them. We find that PGD2 binds vertically to DP in the TM1237 region with the α chain toward the extracellular (EC) region and the ω chain toward the middle of the membrane. This structure explains the selectivity of the DP receptor and the residues involved in the predicted binding site correlate very well with available mutation experiments on DP, IP, TP, FP, and EP subtypes. We report molecular dynamics of DP in explicit lipid and water and find that the binding of the PGD2 agonist leads to correlated rotations of helices of TM3 and TM7, whereas binding of antagonist leads to no such rotations. Thus, these motions may be related to the mechanism of activation.
Additional Information
© 2007 American Chemical Society. Received 13 February 2007. Published online 11 August 2007. Published in print 1 September 2007. Support for the Caltech activities was provided by Sanofi-Aventis Corporation with additional support from NIH (R21-MH073910-01-A1). The computational resources for these studies were provided by grants from ARO-DURIP and ONR-DURIP.Attached Files
Accepted Version - nihms62632.pdf
Supplemental Material - ja070865dsi20070710_012848.pdf
Files
Name | Size | Download all |
---|---|---|
md5:72b95e6f66a506d80130db314ec05952
|
80.3 kB | Preview Download |
md5:85ad5bbcf164e4b3f644745de1043197
|
4.1 MB | Preview Download |
Additional details
- PMCID
- PMC2535578
- Eprint ID
- 77451
- Resolver ID
- CaltechAUTHORS:20170515-111024186
- Sanofi-Aventis Corporation
- NIH
- R21-MH073910-01-A1
- Army Research Office (ARO)
- Office of Naval Research (ONR)
- Created
-
2017-05-16Created from EPrint's datestamp field
- Updated
-
2021-11-15Created from EPrint's last_modified field